Diroximel fumarate clinical trials
Also written Vumerity, BIIB098 and ALK8700.
How each study uses diroximel fumarate is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the diroximel fumarate studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 29 Oct 2019 · VUMERITY · NDA 211855 (FDA, Drugs@FDA)
- European Union
- 15 Nov 2021 · Vumerity · EMEA/H/C/005437 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
7 studies that test it; most in 2021 (2)
| Year | Studies |
|---|---|
| 2015 | 1 |
| 2017 | 1 |
| 2021 | 2 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 5 · Other 2
Biogen (5) · University of Nebraska (1) · King's College London (1)
Often tested with
Tested in the same studies.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test diroximel fumarate.
- Dec 2026Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery DiseaseEarly Phase 1 · University of Nebraska
- Jan 2027Investigating the Effect of Diroximel Fumarate on Glutathione in SchizophreniaNot applicable · King's College London
Studies
Open first, then newest update. How each study uses diroximel fumarate is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Impact of Nrf2 Activation on Macrovascular, Microvascular & Leg Function & Walking Capacity in Peripheral Artery DiseaseRecruitingEarly Phase 1University of NebraskaNCT06319339Written as Vumerity
- A Study to Learn About the Safety of Diroximel Fumarate (DRF) and Dimethyl Fumarate (DMF) and Their Effects on Relapses in Pediatric Participants With Relapsing Forms of Multiple Sclerosis (RMS)Not yet recruitingPhase 3BiogenNCT07483632Written as Diroximel Fumarate
- Investigating the Effect of Diroximel Fumarate on Glutathione in SchizophreniaRecruitingNot applicableKing's College LondonNCT06957808Written as Diroximel fumarate (DRF)
- A Study of Diroximel Fumarate (DRF) in Adult Participants From the Asia-Pacific Region With Relapsing Forms of Multiple Sclerosis (RMS)CompletedPhase 3BiogenNCT05083923Written as Diroximel fumarate
- A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1CompletedPhase 3BiogenNCT02634307Written as ALKS 8700
- A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Diroximel Fumarate (DRF) in Chinese and Caucasian Adult Healthy ParticipantsCompletedPhase 1BiogenNCT05127564Written as Diroximel fumarate
- A Tolerability Study of ALKS 8700 in Subjects With Relapsing Remitting Multiple Sclerosis (RRMS) EVOLVE-MS-2CompletedPhase 3BiogenNCT03093324Written as ALKS 8700
As the comparator · 1 — what is tested is compared with diroximel fumarate
Codes
What other systems call diroximel fumarate · ClinicalTrials.gg INT001853
- MeSH (NLM) C000722501diroximel fumarateOne source ClinicalTrials.gov
- UNII (FDA) K0N0Z40J3WDIROXIMEL FUMARATEConfirmed FDA, Wikidata
- RxNorm 2261783One source FDA
- Wikidata Q27281786diroximel fumarateConfirmed FDA, Wikidata
- NCI Thesaurus C169916Diroximel FumarateOne source FDA
- DrugBank DB14783One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C000722501 | diroximel fumarate | One source ClinicalTrials.gov |
| UNII (FDA) | K0N0Z40J3W | DIROXIMEL FUMARATE | Confirmed FDA, Wikidata |
| RxNorm | 2261783 | — | One source FDA |
| Wikidata | Q27281786 | diroximel fumarate | Confirmed FDA, Wikidata |
| NCI Thesaurus | C169916 | Diroximel Fumarate | One source FDA |
| DrugBank | DB14783 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.